CN110468117B - 一种有机溶剂耐受的脂肪酶突变体及其应用 - Google Patents
一种有机溶剂耐受的脂肪酶突变体及其应用 Download PDFInfo
- Publication number
- CN110468117B CN110468117B CN201910844700.1A CN201910844700A CN110468117B CN 110468117 B CN110468117 B CN 110468117B CN 201910844700 A CN201910844700 A CN 201910844700A CN 110468117 B CN110468117 B CN 110468117B
- Authority
- CN
- China
- Prior art keywords
- organic solvent
- mutant
- ala
- gly
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090001060 Lipase Proteins 0.000 title claims abstract description 41
- 102000004882 Lipase Human genes 0.000 title claims abstract description 40
- 239000004367 Lipase Substances 0.000 title claims abstract description 39
- 235000019421 lipase Nutrition 0.000 title claims abstract description 39
- 239000003960 organic solvent Substances 0.000 title claims abstract description 30
- 150000002148 esters Chemical class 0.000 claims abstract description 8
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims abstract description 7
- 235000019634 flavors Nutrition 0.000 claims abstract description 7
- 239000003225 biodiesel Substances 0.000 claims abstract description 4
- 239000013612 plasmid Substances 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 238000003786 synthesis reaction Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 22
- 108090000790 Enzymes Proteins 0.000 abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 10
- 241000894006 Bacteria Species 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 238000012916 structural analysis Methods 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 15
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 102000015925 Proto-oncogene Mas Human genes 0.000 description 8
- 108050004181 Proto-oncogene Mas Proteins 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 7
- XMXLVNVGGJBUPF-UHFFFAOYSA-N 2-amino-n,n-diethyl-1,3-benzothiazole-6-carboxamide Chemical compound CCN(CC)C(=O)C1=CC=C2N=C(N)SC2=C1 XMXLVNVGGJBUPF-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OFHXPCLWHLXQHT-JKQORVJESA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN OFHXPCLWHLXQHT-JKQORVJESA-N 0.000 description 2
- WQVFQXXBNHHPLX-ZKWXMUAHSA-N Ala-Ala-His Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O WQVFQXXBNHHPLX-ZKWXMUAHSA-N 0.000 description 2
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 2
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 2
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 2
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 2
- BGNLUHXLSAQYRQ-FXQIFTODSA-N Ala-Glu-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O BGNLUHXLSAQYRQ-FXQIFTODSA-N 0.000 description 2
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 2
- FQNILRVJOJBFFC-FXQIFTODSA-N Ala-Pro-Asp Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N FQNILRVJOJBFFC-FXQIFTODSA-N 0.000 description 2
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 2
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- SAHQGRZIQVEJPF-JXUBOQSCSA-N Ala-Thr-Lys Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN SAHQGRZIQVEJPF-JXUBOQSCSA-N 0.000 description 2
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 2
- VXLBDJWTONZHJN-YUMQZZPRSA-N Asn-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N VXLBDJWTONZHJN-YUMQZZPRSA-N 0.000 description 2
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 2
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 2
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 2
- PRXCTTWKGJAPMT-ZLUOBGJFSA-N Cys-Ala-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O PRXCTTWKGJAPMT-ZLUOBGJFSA-N 0.000 description 2
- XBELMDARIGXDKY-GUBZILKMSA-N Cys-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)N XBELMDARIGXDKY-GUBZILKMSA-N 0.000 description 2
- ZPASCJBSSCRWMC-GVXVVHGQSA-N Glu-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N ZPASCJBSSCRWMC-GVXVVHGQSA-N 0.000 description 2
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 2
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 2
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 2
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 2
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 2
- LLWQVJNHMYBLLK-CDMKHQONSA-N Gly-Thr-Phe Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLWQVJNHMYBLLK-CDMKHQONSA-N 0.000 description 2
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 2
- NBJAAWYRLGCJOF-UGYAYLCHSA-N Ile-Asp-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N NBJAAWYRLGCJOF-UGYAYLCHSA-N 0.000 description 2
- QGXQHJQPAPMACW-PPCPHDFISA-N Ile-Thr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QGXQHJQPAPMACW-PPCPHDFISA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 2
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 2
- YFBBUHJJUXXZOF-UWVGGRQHSA-N Leu-Gly-Pro Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O YFBBUHJJUXXZOF-UWVGGRQHSA-N 0.000 description 2
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 2
- QNTJIDXQHWUBKC-BZSNNMDCSA-N Leu-Lys-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QNTJIDXQHWUBKC-BZSNNMDCSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 2
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 2
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 2
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 2
- OBPCXINRFKHSRY-SDDRHHMPSA-N Met-Met-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N OBPCXINRFKHSRY-SDDRHHMPSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- SFKOEHXABNPLRT-KBPBESRZSA-N Phe-His-Gly Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(O)=O SFKOEHXABNPLRT-KBPBESRZSA-N 0.000 description 2
- JSGWNFKWZNPDAV-YDHLFZDLSA-N Phe-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 JSGWNFKWZNPDAV-YDHLFZDLSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 2
- HAEGAELAYWSUNC-WPRPVWTQSA-N Pro-Gly-Val Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAEGAELAYWSUNC-WPRPVWTQSA-N 0.000 description 2
- BUEIYHBJHCDAMI-UFYCRDLUSA-N Pro-Phe-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BUEIYHBJHCDAMI-UFYCRDLUSA-N 0.000 description 2
- GZNYIXWOIUFLGO-ZJDVBMNYSA-N Pro-Thr-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZNYIXWOIUFLGO-ZJDVBMNYSA-N 0.000 description 2
- ZYJMLBCDFPIGNL-JYJNAYRXSA-N Pro-Tyr-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O ZYJMLBCDFPIGNL-JYJNAYRXSA-N 0.000 description 2
- OHKLFYXEOGGGCK-ZLUOBGJFSA-N Ser-Asp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OHKLFYXEOGGGCK-ZLUOBGJFSA-N 0.000 description 2
- XWCYBVBLJRWOFR-WDSKDSINSA-N Ser-Gln-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O XWCYBVBLJRWOFR-WDSKDSINSA-N 0.000 description 2
- QUGRFWPMPVIAPW-IHRRRGAJSA-N Ser-Pro-Phe Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QUGRFWPMPVIAPW-IHRRRGAJSA-N 0.000 description 2
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 2
- CRZNCABIJLRFKZ-IUKAMOBKSA-N Thr-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N CRZNCABIJLRFKZ-IUKAMOBKSA-N 0.000 description 2
- WTMPKZWHRCMMMT-KZVJFYERSA-N Thr-Pro-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WTMPKZWHRCMMMT-KZVJFYERSA-N 0.000 description 2
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 2
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 description 2
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 2
- ILUOMMDDGREELW-OSUNSFLBSA-N Thr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O ILUOMMDDGREELW-OSUNSFLBSA-N 0.000 description 2
- QNXZCKMXHPULME-ZNSHCXBVSA-N Thr-Val-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O QNXZCKMXHPULME-ZNSHCXBVSA-N 0.000 description 2
- DXDMNBJJEXYMLA-UBHSHLNASA-N Trp-Asn-Asp Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 DXDMNBJJEXYMLA-UBHSHLNASA-N 0.000 description 2
- WMBFONUKQXGLMU-WDSOQIARSA-N Trp-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N WMBFONUKQXGLMU-WDSOQIARSA-N 0.000 description 2
- IXTQGBGHWQEEDE-AVGNSLFASA-N Tyr-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IXTQGBGHWQEEDE-AVGNSLFASA-N 0.000 description 2
- JWGXUKHIKXZWNG-RYUDHWBXSA-N Tyr-Gly-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O JWGXUKHIKXZWNG-RYUDHWBXSA-N 0.000 description 2
- KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 2
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 2
- GMOLURHJBLOBFW-ONGXEEELSA-N Val-Gly-His Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N GMOLURHJBLOBFW-ONGXEEELSA-N 0.000 description 2
- PMDOQZFYGWZSTK-LSJOCFKGSA-N Val-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C PMDOQZFYGWZSTK-LSJOCFKGSA-N 0.000 description 2
- UKEVLVBHRKWECS-LSJOCFKGSA-N Val-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)N UKEVLVBHRKWECS-LSJOCFKGSA-N 0.000 description 2
- QIVPZSWBBHRNBA-JYJNAYRXSA-N Val-Pro-Phe Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O QIVPZSWBBHRNBA-JYJNAYRXSA-N 0.000 description 2
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- -1 i.e. Proteins 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 102220591835 Charged multivesicular body protein 3_V48D_mutation Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101150021286 MAS1 gene Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000006167 equilibration buffer Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/649—Biodiesel, i.e. fatty acid alkyl esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种有机溶剂耐受的脂肪酶突变体及其应用,属于基因工程及酶工程技术领域,本发明基于酶蛋白结构分析,设计及构建酶突变库,筛选获得对有机溶剂耐受性增强的脂肪酶突变体,并构建得到高效表达该突变体的毕赤酵母工程菌,该有机溶剂耐受性增强的脂肪酶突变体,相对于野生型在对耐受有机溶剂的能力显著增强,在50%的乙醇处理2小时,其残余活力仍保留是75%,约为是野生型的3倍;该脂肪酶突变体可在生物柴油及风味酯制备加工过程中应用,具有良好的稳定性能,可在应用过程中寿命延长,节约生产成本和提高生产效率。
Description
技术领域
本发明涉及基因工程及酶工程领域,特别是涉及一种有机溶剂耐受的脂肪酶突变体及其应用。
背景技术
脂肪酶,即三酰基甘油酰基水解酶,它催化天然底物油脂水解,生成脂肪酸、甘油和甘油单酯或二酯。脂肪酶基本组成单位仅为氨基酸,通常只有一条多肽链。它的催化活性仅仅决定于它的蛋白质结构(Schmid等,1998)。脂肪酶具有广泛的应用价值,已成为市场上的第三大工业用酶。脂肪酶可以催化解脂、酯交换、酯合成等反应,广泛应用于饲料添加剂、油脂加工、食品、医药、日化等工业。
脂肪酶在水环境中能够催化酯键的水解,当处于有机溶剂环境中能催化酯交换,酯化,醇解,酸解等反应。而脂肪酶作用的底物往往是水不溶性的,在有机相中才有较好的溶解度,但是在有机溶剂中,大多数酶类活力受到抑制甚至失活,所以其在生物催化中的应用受到很大限制。在有机介质中维持较高的脂肪酶活性及脂肪酶催化底物的广泛性是实际生物催化过程中的难题。因此开发耐有机溶剂脂肪酶在理论和工业应用上具有重要的意义。
发明内容
本发明的目的是提供一种有机溶剂耐受的脂肪酶突变体及其应用,以解决上述现有技术存在的问题,该脂肪酶突变体可应用于风味酯的合成及生物柴油的生产,其具有良好的稳定性能,可在应用过程中寿命延长,节约生产成本和提高生产效率。
为实现上述目的,本发明提供了如下方案:
本发明提供一种有机溶剂耐受的脂肪酶突变体,所述有机溶剂耐受的脂肪酶突变体是氨基酸序列为SEQ ID NO.1的脂肪酶的第191位氨基酸由Arg变为Ala。
上述有机溶剂耐受的脂肪酶突变体的氨基酸序列为SEQ ID NO.2。
上述有机溶剂耐受的脂肪酶突变体的编码基因的核酸序列为SEQ ID NO.3。
本发明还提供一种在宿主细胞内表达氨基酸序列为SEQ ID NO.2的有机溶剂耐受的脂肪酶突变体的重组质粒。
进一步地,所述重组质粒含有序列为SEQ ID NO.3的核酸。
本发明还提供一种工程菌株,所述工程菌含有在宿主细胞内表达氨基酸序列为SEQID NO.2的有机溶剂耐受的脂肪酶突变体的重组质粒或含有核酸序列为SEQ ID NO.3的重组质粒。
进一步地,所述工程菌株为巴斯德毕赤酵母Pichia pastoris。
本发明还提供上述的有机溶剂耐受的脂肪酶突变体、上述的重组质粒、上述的工程菌株在风味酯物质及生物柴油合成中的应用。
本发明公开了以下技术效果:
本发明基于酶蛋白结构分析,设计及构建酶突变库,筛选获得对有机溶剂耐受性增强的脂肪酶突变体,并构建得到高效表达该突变体的毕赤酵母工程菌,该有机溶剂耐受性增强的脂肪酶突变体,相对于野生型在对耐受有机溶剂的能力显著增强,在50%的乙醇处理2小时,其残余活力仍保留75%,约为是野生型的3倍;该脂肪酶突变体可在生物柴油及风味酯制备加工过程中应用,具有良好的稳定性能,可在应用过程中寿命延长,节约生产成本和提高生产效率。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。
图1为实施例3有机溶剂耐受脂肪酶突变体的筛选酶活对比图;
图2为实施例3中R191A突变体在不同溶剂中耐受能力对比图;
图3为实施例5的MAS1及R191A突变体合成己酸乙酯的合成效率对比图。
具体实施方式
现详细说明本发明的多种示例性实施方式,该详细说明不应认为是对本发明的限制,而应理解为是对本发明的某些方面、特性和实施方案的更详细的描述。
应理解本发明中所述的术语仅仅是为描述特别的实施方式,并非用于限制本发明。另外,对于本发明中的数值范围,应理解为还具体公开了该范围的上限和下限之间的每个中间值。在任何陈述值或陈述范围内的中间值以及任何其他陈述值或在所述范围内的中间值之间的每个较小的范围也包括在本发明内。这些较小范围的上限和下限可独立地包括或排除在范围内。
除非另有说明,否则本文使用的所有技术和科学术语具有本发明所述领域的常规技术人员通常理解的相同含义。虽然本发明仅描述了优选的方法和材料,但是在本发明的实施或测试中也可以使用与本文所述相似或等同的任何方法和材料。本说明书中提到的所有文献通过引用并入,用以公开和描述与所述文献相关的方法和/或材料。在与任何并入的文献冲突时,以本说明书的内容为准。
在不背离本发明的范围或精神的情况下,可对本发明说明书的具体实施方式做多种改进和变化,这对本领域技术人员而言是显而易见的。由本发明的说明书得到的其他实施方式对技术人员而言是显而易见得的。本申请说明书和实施例仅是示例性的。
关于本文中所使用的“包含”、“包括”、“具有”、“含有”等等,均为开放性的用语,即意指包含但不限于。
实施例1突变体表达载体的构建
根据Stratagene公司的QuikChange方案,在QuikChange引物设计网站(http://www.genomics.agilent.com/primerDesignProgram.jsp)设计了突变体R191A、Q201A、V203A、V199F、H139R、V48D及P252D引物。采取的定点突变(QuikChange Site-directedMutagenesis)中对脂肪酶MAS1基因进行定点突变。具体如表1所示:
表1脂肪酶基因定点突变的反应体系
PCR反应条件为:98℃预变性3min;94℃变性10s,68℃延伸4min,20个循环;72℃7min。PCR产物采用1%的琼脂糖凝胶电泳检验。PCR产物经检测确认后,加入DpnI处理去除带甲基化的原始模板链。酶切体系如下:酶切反应条件:37℃,1h。
将酶切产物转化到大肠杆菌DH5α感受态中,涂布在含Amp的LB平板,在37℃恒温培养箱中过夜培养。挑取单克隆接种于5mL的LB培养基中,在37℃下过夜培养,提取质粒进行基因序列测定。
实施例2突变体酶蛋白制备与纯化
将含有MAS1脂肪酶(氨基酸序列为SEQ ID NO:1)及其突变体基因的pET22b表达载体转化到BL21(DE3)菌种中,并进行诱导表达:
(1)接种200μL阳性克隆子甘油菌到50mL低盐LB(含100μg/mL氨苄青霉素)液体培养基中,37℃、200rpm过夜培养15~18h。
(2)按2%接种量将种子液接种到500mL LB(含100μg/mL氨苄青霉素)液体培养基中,37℃、200rpm培养OD600至0.6~0.8,然后加入1M IPTG溶液至IPTG终浓度为0.4mM,15℃、200rpm诱导培养18h。
诱导结束后进行重组蛋白的纯化:
(1)收菌:将菌液置于冰上预冷约15min,然后于4℃、10000rpm条件下离心10min,弃上清。
(2)破菌收集上清:用预冷的PBS溶液重悬细胞,超声破碎15min,然后在4℃,10000rpm条件下离心10min收集细胞裂解液。所得细胞裂解液通过0.45μm滤膜抽滤以进一步除去菌体和悬浮杂质。
(3)镍柱亲和层析:重组MAS1及其突变体蛋白的纯化采用镍柱亲和层析的方法,柱子选用His trapTm 5mL预装柱。首先用超纯水除去用于保护填料的乙醇,再用平衡缓冲液(pH7.4 20mM磷酸盐缓冲液,含20mM咪唑和0.5M NaCl)平衡镍柱填料,待A280处吸光值、电导率等参数显示平衡即完成平衡过程。接着将抽滤后的细胞裂解液上样到镍柱中,待上样完成后继续用平衡缓冲液洗去未与填料结合的蛋白。待A280处吸光值、电导率等参数显示平衡后,用含有20~500mM咪唑的洗脱液(20mM磷酸盐缓冲液,pH7.4,含1M NaCl)进行分步洗脱,全过程流速保持在5mL/min。分管收集洗脱液样品置于4℃保存并进行SDS-PAGE检测。
实施例3耐受有机溶剂突变体的筛选
酶活力测定采用碱式滴定法,具体方法为:在100mL具塞锥形瓶中加入4mL橄榄油聚乙烯醇乳化液和5mL缓冲液于恒温水浴摇床下预热5min,然后实验组加入1mL适当稀释的酶液,对照组加入1mL蛋白所在的缓冲液,200rpm反应5min后,加入15mL 95%乙醇终止反应。反应结束后加入2滴酚酞溶液,用0.05mol/L NaOH标准溶液滴定。在一定的反应条件下,每分钟催化底物水解生成1μmol脂肪酸所需要的酶量定义为1个酶活力单位,用U表示。
有机溶剂对酶稳定性的影响:加入甲醇、乙醇、异丙醇和丙酮,使有机溶剂终浓度为50%(v/v),置于37℃孵育2h,在最适反应条件下以橄榄油聚乙烯醇乳化液为底物测定酶活力,所有实验重复三次。有机溶剂对MAS1及其突变体酶活力的影响用相对酶活力表示,以未加入有机溶剂蛋白样品测定的酶活力定为100%。。首先利用乙醇对MAS1及其突变体进行筛选,结果如图1所示,其中R191A(氨基酸序列为SEQ ID NO:2)突变体耐受乙醇能力较好,仍残留75%的活力,野生型的仅为25%的活力。利用不同溶剂对R191A进行酶活力测定,结果如图2所示,R191A突变体对其他有机溶剂也表现出良好的耐受性能。
实施例4酶蛋白在毕赤酵母中的表达制备
将MAS1-R119A基因(核苷酸序列SEQ ID NO:3)克隆到毕赤酵母表达载体pPICZαA载体中,获得pPICZαA-MAS1-R191A表达载体。测序正确后,将载体进行线性化并电转化到毕赤酵母X-33菌种中,利用高浓度Zeocin抗生素进行筛选,获得阳性重组表达菌种,并通过少量验证表达。
在发酵罐中进行培养发酵重组菌,诱导的表达条件设定为:诱导温度24℃和pH值6.0,并诱导培养8天,发酵的酶活单位超过5000U/mL。发酵过程结束后,离心获得发酵液上清,通过30KDa的膜包浓缩,获得酶制剂。
实施例5风味酯合成中的应用
以己酸与乙醇为底物的酯化反应体系来考察MAS1脂肪酶及MAS1-突变体合成风味酯己酸乙酯的能力。具体反应体系如下:己酸:乙醇摩尔比为1:2,加酶量为60U/mL(反应体系体积),初始加水量为0.5%,45度反应24小时,检测产物及反应物的含量变化,并计算转化率,如图3所示,有机溶剂耐受性增强有效提升合成风味内酯能力,MAS1-突变体24小时后合成己酸乙酯的转化率为96%,而野生型的为67%。
以上所述的实施例仅是对本发明的优选方式进行描述,并非对本发明的范围进行限定,在不脱离本发明设计精神的前提下,本领域普通技术人员对本发明的技术方案做出的各种变形和改进,均应落入本发明权利要求书确定的保护范围内。
序列表
<110> 华南理工大学
<120> 一种有机溶剂耐受的脂肪酶突变体及其应用
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 265
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 1
Ala Thr Ala Thr Ala Ala Thr Pro Ala Ala Glu Ala Thr Ser Arg Gly
1 5 10 15
Trp Asn Asp Tyr Ser Cys Lys Pro Ser Ala Ala His Pro Arg Pro Val
20 25 30
Val Leu Val His Gly Thr Phe Gly Asn Ser Ile Asp Asn Trp Leu Val
35 40 45
Leu Ala Pro Tyr Leu Val Asn Arg Gly Tyr Cys Val Phe Ser Leu Asp
50 55 60
Tyr Gly Gln Leu Pro Gly Val Pro Phe Phe His Gly Leu Gly Pro Ile
65 70 75 80
Asp Lys Ser Ala Glu Gln Leu Asp Val Phe Val Asp Lys Val Leu Asp
85 90 95
Ala Thr Gly Ala Pro Lys Ala Asp Leu Val Gly His Ser Gln Gly Gly
100 105 110
Met Met Pro Asn Tyr Tyr Leu Lys Phe Leu Gly Gly Ala Asp Lys Val
115 120 125
Asn Ala Leu Val Gly Ile Ala Pro Asp Asn His Gly Thr Thr Leu Leu
130 135 140
Gly Leu Thr Lys Leu Leu Pro Phe Phe Pro Gly Val Glu Lys Phe Ile
145 150 155 160
Ser Asp Asn Thr Pro Gly Leu Ala Asp Gln Val Ala Gly Ser Pro Phe
165 170 175
Ile Thr Lys Leu Thr Ala Gly Gly Asp Thr Val Pro Gly Val Ala Tyr
180 185 190
Thr Val Ile Ala Thr Lys Tyr Asp Gln Val Val Thr Pro Tyr Arg Thr
195 200 205
Gln Tyr Leu Asp Gly Pro Asn Val Arg Asn Val Leu Leu Gln Asp Leu
210 215 220
Cys Pro Val Asp Leu Ser Glu His Val Ala Ile Gly Thr Ile Asp Arg
225 230 235 240
Ile Ala Phe His Glu Val Ala Asn Ala Leu Asp Pro Ala Arg Ala Thr
245 250 255
Pro Thr Thr Cys Ala Ser Val Ile Gly
260 265
<210> 2
<211> 265
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 2
Ala Thr Ala Thr Ala Ala Thr Pro Ala Ala Glu Ala Thr Ser Arg Gly
1 5 10 15
Trp Asn Asp Tyr Ser Cys Lys Pro Ser Ala Ala His Pro Arg Pro Val
20 25 30
Val Leu Val His Gly Thr Phe Gly Asn Ser Ile Asp Asn Trp Leu Val
35 40 45
Leu Ala Pro Tyr Leu Val Asn Arg Gly Tyr Cys Val Phe Ser Leu Asp
50 55 60
Tyr Gly Gln Leu Pro Gly Val Pro Phe Phe His Gly Leu Gly Pro Ile
65 70 75 80
Asp Lys Ser Ala Glu Gln Leu Asp Val Phe Val Asp Lys Val Leu Asp
85 90 95
Ala Thr Gly Ala Pro Lys Ala Asp Leu Val Gly His Ser Gln Gly Gly
100 105 110
Met Met Pro Asn Tyr Tyr Leu Lys Phe Leu Gly Gly Ala Asp Lys Val
115 120 125
Asn Ala Leu Val Gly Ile Ala Pro Asp Asn His Gly Thr Thr Leu Leu
130 135 140
Gly Leu Thr Lys Leu Leu Pro Phe Phe Pro Gly Val Glu Lys Phe Ile
145 150 155 160
Ser Asp Asn Thr Pro Gly Leu Ala Asp Gln Val Ala Gly Ser Pro Phe
165 170 175
Ile Thr Lys Leu Thr Ala Gly Gly Asp Thr Val Pro Gly Val Ala Tyr
180 185 190
Thr Val Ile Ala Thr Lys Tyr Asp Gln Val Val Thr Pro Tyr Arg Thr
195 200 205
Gln Tyr Leu Asp Gly Pro Asn Val Arg Asn Val Leu Leu Gln Asp Leu
210 215 220
Cys Pro Val Asp Leu Ser Glu His Val Ala Ile Gly Thr Ile Asp Arg
225 230 235 240
Ile Ala Phe His Glu Val Ala Asn Ala Leu Asp Pro Ala Arg Ala Thr
245 250 255
Pro Thr Thr Cys Ala Ser Val Ile Gly
260 265
<210> 3
<211> 783
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 3
gccacgccag ctgctgaggc tacttcccga ggttggaacg actattcttg taagccctct 60
gctgcccatc ctagacctgt tgttcttgta catggcacct tcggtaactc aattgacaac 120
tggcttgttt tggctccata cttggtaaat agaggttact gcgtcttttc tctggactac 180
ggtcaacttc ctggtgttcc attctttcat ggacttggtc ctatcgacaa gtccgccgaa 240
caattggacg ttttcgttga taaggtacta gacgccactg gagcccccaa ggctgatctg 300
gtcggtcaca gtcaaggtgg tatgatgcca aactactacc tgaaattctt aggaggggca 360
gataaggtta acgcattggt tggaatagct ccagataatc acggcaccac tttactaggc 420
ctaactaaat tgttaccctt tttcccaggg gttgaaaaat ttatttctga caatacccca 480
gggttagcag accaagtcgc tggttcccct tttattacaa aattgacagc cggaggtgat 540
actgtgccag gagttgcgta caccgtcatt gcaactaaat atgatcaggt ggttacacct 600
tatcgtactc agtatttgga tggacctaac gtcagaaatg tcttgctgca ggatctttgt 660
ccagtggatt tgtcagaaca cgtagccatc ggaactatcg ataggatagc ttttcatgag 720
gtggctaatg cactggatcc agctagagca acacctacaa cctgtgcttc tgtgattggc 780
tga 783
Claims (5)
1.一种有机溶剂耐受的脂肪酶突变体,其特征在于,所述有机溶剂耐受的脂肪酶突变体的氨基酸序列为SEQ ID NO.2。
2.一种重组质粒,其特征在于,其用于在宿主细胞内表达权利要求1所述的有机溶剂耐受的脂肪酶突变体。
3.一种工程菌株,其特征在于,所述工程菌含有权利要求2所述的重组质粒。
4.根据权利要求3所述的工程菌株,其特征在于,所述工程菌株为巴斯德毕赤酵母Pichia pastoris。
5.权利要求1所述的有机溶剂耐受的脂肪酶突变体、权利要求2所述的重组质粒、权利要求3或4所述的工程菌株在风味酯物质及生物柴油合成中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910844700.1A CN110468117B (zh) | 2019-09-07 | 2019-09-07 | 一种有机溶剂耐受的脂肪酶突变体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910844700.1A CN110468117B (zh) | 2019-09-07 | 2019-09-07 | 一种有机溶剂耐受的脂肪酶突变体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110468117A CN110468117A (zh) | 2019-11-19 |
CN110468117B true CN110468117B (zh) | 2021-03-09 |
Family
ID=68515196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910844700.1A Expired - Fee Related CN110468117B (zh) | 2019-09-07 | 2019-09-07 | 一种有机溶剂耐受的脂肪酶突变体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110468117B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114921437B (zh) * | 2022-05-26 | 2023-09-19 | 华南理工大学 | 海洋链霉菌脂肪酶突变体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103361326B (zh) * | 2013-07-08 | 2014-07-02 | 华南理工大学 | 一种耐热性提高的偏甘油酯脂肪酶突变体及突变质粒、重组菌株和制备方法 |
CN106047837B (zh) * | 2016-06-01 | 2019-08-16 | 华东理工大学 | 沙雷氏菌脂肪酶突变体、重组表达转化子、酶制剂及应用 |
WO2018154048A1 (en) * | 2017-02-24 | 2018-08-30 | Basf Se | Method for the preparation of (3e,7e)-homofarnesic acid or (3e,7e)-homofarnesic acid ester |
-
2019
- 2019-09-07 CN CN201910844700.1A patent/CN110468117B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
Residue Asn277 Affects the Stability and Substrate Specificity of the SMG1 Lipase from Malassezia globosa;Lan, Dongming;《INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES》;20150430;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN110468117A (zh) | 2019-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110540980B (zh) | 一种海洋链霉菌脂肪酶突变体及其应用 | |
CN108642026B (zh) | 一种偏甘油酯脂肪酶突变体及其应用 | |
CN109055346B (zh) | 一种热稳定性提高的L-天冬氨酸-α-脱羧酶 | |
CN110938616B (zh) | 一种温泉热碱芽孢杆菌来源的腈水合酶的突变体 | |
Feng et al. | Enhancing the thermostability of β-glucuronidase by rationally redesigning the catalytic domain based on sequence alignment strategy | |
e Cunha et al. | Structural differences of commercial and recombinant lipase B from Candida antarctica: An important implication on enzymes thermostability | |
CN107794275B (zh) | 一种产(+)γ-内酰胺酶的重组毕赤酵母及其构建方法和应用 | |
CN109750022A (zh) | 一种褐藻胶裂解酶Alg2A及其制备方法和应用 | |
CN110468117B (zh) | 一种有机溶剂耐受的脂肪酶突变体及其应用 | |
CN107488644B (zh) | 一种热稳定性提高的脂肪酶TTL突变体TTL-Gly60Glu/Ser61Asn及其基因和应用 | |
CN106754818B (zh) | 一种耐热酯酶突变体及其制备方法和应用 | |
WO2017087982A2 (en) | A novel cellulase complex, and glycosidase hydrolases thereof, and methods of using thereof | |
Elmi et al. | Stereoselective esterase from Pseudomonas putida IFO12996 reveals α/β hydrolase folds for D-β-acetylthioisobutyric acid synthesis | |
CN105296513B (zh) | 一种海洋酯酶及其编码基因e22与应用 | |
CN109486780B (zh) | 一种催化效率提高的ω-转氨酶突变体 | |
CN112175919A (zh) | 内酯水解酶突变体及其应用 | |
CN108315312B (zh) | 一种热稳定性提高的脂肪酶ttl突变体及其编码基因和应用 | |
CN108359655B (zh) | 一种热稳定性高的脂肪酶突变体TDL-mut及其编码基因 | |
CN108277212B (zh) | 脂肪酶突变体Gly183Cys/Gly212Cys及其基因和应用 | |
CN107916257B (zh) | T1脂肪酶突变体和应用 | |
CN112301014B (zh) | 一种热稳定性提高的酯酶突变体及其应用 | |
CN110540979B (zh) | 一种双氧水耐受的脂肪酶突变体及其应用 | |
CN112226422B (zh) | 一种活性提高的EstWY酶突变体 | |
CN107488647B (zh) | 一种热稳定性提高的脂肪酶TTL突变体TTL-Gly60Glu及其基因和应用 | |
CN107488648B (zh) | 热稳定性提高的脂肪酶TTL突变体TTL-Arg59Ser/Gly60Glu/Ser61Asn及基因和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Yonghua Inventor after: Chen Siyue Inventor after: Lan Dongming Inventor after: Zhao Zexin Inventor after: Yang Bo Inventor before: Wang Yonghua Inventor before: Lan Dongming Inventor before: Zhao Zexin Inventor before: Yang Bo |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210309 |